Diagnostic Substance Manufacturing Focused Private Equity Firms

Interests: A sale of a subsidiary that no longer fits the strategy is mostly more efficient than its independent liquidation. This is the case whenever liquidation costs are higher than the income from the sale of assets. A potential conflict with employees, the works council or labour unions will also be omitted. A sale can also be used for an advantage in the press (Independent continuation of business while preserving jobs was made possible through the sale” versus “job loss and protests on the factory shut- down). We can realize deals within several weeks. We generally take majority shareholdings, as we want to share as active shareholders in shaping the development of the companies under our management and also want to be able to act in a potential crisis situation. Our target companies ideally fulfil the following participation criteria: • Excellent market position in a niche market. • Company background with a long tradition, leading in terms of the band and/or products. • Exclusively “old economy”, preferably with corporate group history. • Experienced management team or the tangible possibility to install such Additionally, there should be an experienced employee base with low fluctuation. • The operative business continues, high fluctuation among customers and/or suppliers has not begun yet. • Sales revenues of 10 million euro or more are earned, the financial result is making a loss and a restructuring process has not been initiated yet.

Interests: Profitable companies in niche industries such as high-tech, robotics, consumer goods, cosmetics, advanced industrials, food and beverage, med-tech and biotech.

Interests: - Family owned, US-based, differentiated products, manufacturers, or value-added distributors. - We are primarily interested in acquiring a pet care products business, but we are also interested in the pharmaceutical or food & beverage sectors.

Interests: - Family owned, US-based, differentiated products, manufacturers, or value-added distributors. - We are primarily interested in acquiring a pet care products business, but we are also interested in the pharmaceutical or food & beverage sectors.

Interests: Only want to buyout a B2B SaaS business.

Interests: A stable company operating for more than 5 years with equity investment size in the range of US$ 15-20 million for equity ownership of 49% or less.

Interests: Growing business, prompt margin, scalability, ROI, operations team.

Interests: We typically invest in middle market companies and partner with companies, at any stage of their growth. We can move quickly on both due diligence and closing.

Interests: Looking for a company in a growing industry with an attractive revenue model. The business should be asset-light with greater than 80% customer retention.

Interests: Free cash flow, high return on invested capital, robust end markets and strong market position.

Interests: Mid-sized growth companies with an India focus.

Interests: Looking for B2B businesses in the US or Canada only with.

Interests: Through our buy & build acquisition strategy, we are operationally focused value investors looking to accelerate growth and assist firms scale. We typically prefer situations where sellers are willing to retain a meaningful equity stake thereby creating a true partnership dynamic. The company should have revenues of revenues of USD $20 million to USD $200 million and EBITDA of up to USD $20 million.

Interests: Professional management, potential to scale and profitability. Our focus areas are Financials and Healthcare including Fintech and Healthtech. We help our portfolio companies with talent acquisition, strategic business alliances, access to debt market, prepare for an IPO, strengthen corporate governance, thereby creating value for promoters as well as its investors.

Interests: Want to look at companies operating mostly in Consumer Space - Wellness & Spa, FMCG Companies, Ready to Eat, Organic Food, etc.